SCHEMBL25580977

SCHEMBL25580977

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2cccc(N(c3ccccc3)c3cccc4oc5ccccc5c34)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.33
▸ CRHR1 P34998 1/20 0.32
▸ CDC14B O60729 1/20 0.32
▸ CDC14A Q9UNH5 1/20 0.32
▸ CA1 P00915 2/20 0.31
▸ CA2 P00918 2/20 0.31
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ TNKS O95271 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ ABCB1 P08183 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ PARP1 P09874 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ AR P10275 1/20 0.31
▸ CYP19A1 P11511 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580813 0.96 ALOX5 (0.33) ALOX5CRHR1CDC14BCDC14ATNKS
SCHEMBL25580912 0.96 ALOX5 (0.33) ALOX5CRHR1CDC14BCDC14ATNKS
SCHEMBL25580843 0.94 ALOX5 (0.32) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL24370030 0.94 ALOX5 (0.36) ALOX5CRHR1CDC14BCDC14ACA1
SCHEMBL25580789 0.93 MCL1 (0.35) ALOX5CA1CA2CA12TP53
SCHEMBL25580700 0.93 CDC14B (0.33) ALOX5CRHR1CDC14BCDC14ACA1
SCHEMBL24370011 0.93 ALOX5 (0.36) ALOX5CRHR1CDC14BCDC14ACA1
SCHEMBL25581003 0.92 MCL1 (0.36) ALOX5CRHR1CA1CA2CA12
SCHEMBL25580476 0.92 MCL1 (0.36) ALOX5CRHR1CA1CA2CA12
SCHEMBL25580959 0.92 ALOX5 (0.33) ALOX5CDC14BCDC14A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885CRHR1 2237/4885CDC14B 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback